Who are the main bulk suppliers for Pantoprazole injection?
Major bulk suppliers for pantoprazole injection include companies like Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Mylan N.V. (now Viatris), and Sun Pharmaceutical Industries [1][2]. These companies are significant manufacturers of generic pharmaceuticals, including pantoprazole.
What is Pantoprazole injection used for?
Pantoprazole injection is a proton pump inhibitor (PPI) used to treat certain stomach and esophagus problems, such as damage from heartburn and gastroesophageal reflux disease (GERD) [3]. It works by decreasing the amount of acid the stomach produces, allowing existing damage to heal and preventing further damage [3].
When can generic Pantoprazole injections enter the market?
The market entry for generic pantoprazole injections is influenced by patent expirations and exclusivity periods. According to DrugPatentWatch.com, specific patent expiry dates and associated exclusivity for pantoprazole can vary depending on the region and the specific patent [4]. For instance, while innovator drug patents might expire, other patents related to formulation or method of use could extend market protection.
What is the difference between Pantoprazole tablets and injection?
The primary difference lies in their administration and speed of action. Pantoprazole tablets are taken orally and are suitable for long-term maintenance treatment of GERD or for patients who can swallow pills. Pantoprazole injection is administered intravenously and is typically used when oral administration is not possible or when a rapid reduction in stomach acid is needed, such as in hospital settings for conditions like upper gastrointestinal bleeding [3][5].
What is the patent landscape for Pantoprazole?
The patent landscape for pantoprazole involves patents covering the active pharmaceutical ingredient, various formulations, and methods of use. Understanding these patents is crucial for generic manufacturers seeking to enter the market [4]. DrugPatentWatch.com provides detailed patent information for drugs like pantoprazole, including expiry dates and patent holders [4].
What regulatory hurdles exist for Pantoprazole injection manufacturers?
Manufacturers of pantoprazole injection must obtain approval from regulatory agencies like the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA). This involves demonstrating the drug's safety, efficacy, and quality through rigorous testing and submission of a comprehensive New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) for generics [6].
Where can I find more detailed patent information for Pantoprazole?
Detailed information on pantoprazole patents, including expiration dates, patent holders, and related litigation, can be found on DrugPatentWatch.com [4]. This resource tracks patent data for a wide range of pharmaceuticals.
Cited Sources
1. Teva Pharmaceutical Industries Ltd.
2. Dr. Reddy's Laboratories Ltd.
3. Mayo Clinic
4. DrugPatentWatch.com
5. Cleveland Clinic
6. U.S. Food and Drug Administration